Stay updated on Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.
Latest updates to the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a dedicated Locations section with Connecticut as a study site, replacing the former Connecticut Locations entry.SummaryDifference0.2%
- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2, a minor maintenance/version change that does not affect trial content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check42 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.1; no substantive changes to the page content are observed.SummaryDifference0.1%
- Check49 days agoChange DetectedRemoved the government funding operating status notice from the page; core study details remain unchanged.SummaryDifference0.4%
- Check63 days agoChange DetectedThe updates appear cosmetic and do not affect core trial details such as eligibility criteria, endpoints, or treatment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check92 days agoChange DetectedAdd: government funding notice and open status with external links; Update: version to v3.2.0. Delete: a specific resource entry for small cell lung carcinoma (v3.1.0).SummaryDifference4%
Stay in the know with updates to Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.